Susan C Pitt1, Rebecca S Sippel, Herbert Chen. 1. Section of Endocrine Surgery, Department of Surgery, University of Wisconsin, Madison, WI, USA. pitt@surgery.wisc.edu
Abstract
BACKGROUND: The optimal extent of thyroidectomy for papillary thyroid cancer (PTC) <1 cm is controversial. Our aim was to identify the rate and factors predictive of contralateral PTC in these patients. METHODS: We examined 228 patients with PTC who underwent either completion or total thyroidectomy and analyzed the predictive value of tumor size, histology, margin status, capsular invasion, extrathyroid extension, multifocality, and node metastases. RESULTS: We observed no differences in the rate of contralateral disease in patients with primary PTC > or =1 cm compared with those having disease <1 cm, 30% versus 24%, respectively (P = .43). Multifocality was the only factor predictive of contralateral PTC in patients with tumors <1 cm (P = .02). Patients with tumors <.5 cm also had a comparable rate of contralateral disease (27%). CONCLUSIONS: The presence of contralateral PTC appears to be unrelated to the size of the primary tumor. Furthermore, in patients with PTC <1 cm, multifocality is a risk factor for PTC in the contralateral lobe.
BACKGROUND: The optimal extent of thyroidectomy for papillary thyroid cancer (PTC) <1 cm is controversial. Our aim was to identify the rate and factors predictive of contralateral PTC in these patients. METHODS: We examined 228 patients with PTC who underwent either completion or total thyroidectomy and analyzed the predictive value of tumor size, histology, margin status, capsular invasion, extrathyroid extension, multifocality, and node metastases. RESULTS: We observed no differences in the rate of contralateral disease in patients with primary PTC > or =1 cm compared with those having disease <1 cm, 30% versus 24%, respectively (P = .43). Multifocality was the only factor predictive of contralateral PTC in patients with tumors <1 cm (P = .02). Patients with tumors <.5 cm also had a comparable rate of contralateral disease (27%). CONCLUSIONS: The presence of contralateral PTC appears to be unrelated to the size of the primary tumor. Furthermore, in patients with PTC <1 cm, multifocality is a risk factor for PTC in the contralateral lobe.
Authors: F Pacini; R Elisei; M Capezzone; P Miccoli; E Molinaro; F Basolo; L Agate; V Bottici; M Raffaelli; A Pinchera Journal: Thyroid Date: 2001-09 Impact factor: 6.568
Authors: Il Seong Nam-Goong; Ha Young Kim; Gyungyub Gong; Ho Kyu Lee; Suck Joon Hong; Won Bae Kim; Young Kee Shong Journal: Clin Endocrinol (Oxf) Date: 2004-01 Impact factor: 3.478
Authors: Ian Mitchell; Edward H Livingston; Alice Y Chang; Shelby Holt; William H Snyder; Ildiko Lingvay; Fiemu E Nwariaku Journal: Surgery Date: 2007-12 Impact factor: 3.982
Authors: Young Chan Lee; Young Gyu Eun; Yu-Mee Sohn; Sang Youl Rhee; Il Ki Hong; Suk Chon; Seung Joon Oh; Deog Yoon Kim Journal: World J Surg Date: 2015-07 Impact factor: 3.352
Authors: Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens Journal: Langenbecks Arch Surg Date: 2013-03-03 Impact factor: 3.445